2.4.0.8 Html 290 342 1 false 88 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.marronebioinnovations.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 105 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfIncome Condensed Consolidated Statements of Operations false false R5.htm 106 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Loss false false R6.htm 107 - Statement - Condensed Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Condensed Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit) false false R7.htm 108 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows false false R8.htm 109 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.marronebioinnovations.com/taxonomy/role/StatementOfCashFlowsIndirectParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) false false R9.htm 110 - Disclosure - Summary of Business Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock Summary of Business false false R10.htm 111 - Disclosure - Significant Accounting Policies Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Policies false false R11.htm 112 - Disclosure - Fair Value Measurements Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements false false R12.htm 113 - Disclosure - Short-term Investments Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Short-term Investments false false R13.htm 114 - Disclosure - Inventories Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories false false R14.htm 115 - Disclosure - Net Loss Per Share Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss Per Share false false R15.htm 116 - Disclosure - Other Assets Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsDisclosureTextBlock Other Assets false false R16.htm 117 - Disclosure - Accrued Liabilities Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock Accrued Liabilities false false R17.htm 118 - Disclosure - Factoring and Security Agreement Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFactoringAndSecurityAgreementDisclosureTextBlock Factoring and Security Agreement false false R18.htm 119 - Disclosure - Debt Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt false false R19.htm 120 - Disclosure - Convertible Notes Payable Notes http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsConvertibleNotesPayableDisclosureTextBlock Convertible Notes Payable false false R20.htm 121 - Disclosure - Stock Option Plans Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock Option Plans false false R21.htm 122 - Disclosure - Commitments and Contingencies Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies false false R22.htm 123 - Disclosure - Reverse Stock Split Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsReverseStockSplitTextBlock Reverse Stock Split false false R23.htm 124 - Disclosure - Initial Public Offering Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingTextBlock Initial Public Offering false false R24.htm 125 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Significant Accounting Policies (Policies) false false R25.htm 126 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Significant Accounting Policies (Tables) false false R26.htm 127 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) false false R27.htm 128 - Disclosure - Short-term Investments (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Short-term Investments (Tables) false false R28.htm 129 - Disclosure - Inventories (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) false false R29.htm 130 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Loss Per Share (Tables) false false R30.htm 131 - Disclosure - Other Assets (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsDisclosureTextBlockTables Other Assets (Tables) false false R31.htm 132 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlockTables Accrued Liabilities (Tables) false false R32.htm 133 - Disclosure - Debt (Tables) Sheet http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Debt (Tables) false false R33.htm 134 - Disclosure - Convertible Notes Payable (Tables) Notes http://www.marronebioinnovations.com/taxonomy/role/NotesToFinancialStatementsConvertibleNotesPayableDisclosureTextBlockTables Convertible Notes Payable (Tables) false false R34.htm 135 - Disclosure - Summary of Business - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSummaryOfBusinessAdditionalInformation Summary of Business - Additional Information (Detail) false false R35.htm 136 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation Significant Accounting Policies - Additional Information (Detail) false false R36.htm 137 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationOfCreditRiskPercentage Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Detail) false false R37.htm 138 - Disclosure - Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfConcentrationOfCreditRiskPercentageParenthetical Significant Accounting Policies - Schedule of Concentration of Credit Risk Percentage (Parenthetical) (Detail) false false R38.htm 139 - Disclosure - Significant Accounting Policies - Summary of Estimated Fair Value of Assets Acquired (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEstimatedFairValueOfAssetsAcquired Significant Accounting Policies - Summary of Estimated Fair Value of Assets Acquired (Detail) false false R39.htm 140 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) false false R40.htm 141 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformation Fair Value Measurements - Additional Information (Detail) false false R41.htm 142 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingSignificantUnobservableInputsLevel3 Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) false false R42.htm 143 - Disclosure - Short-term Investments - Amortized Cost and Estimated Fair Values of Short-Term Investments (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureShorttermInvestmentsAmortizedCostAndEstimatedFairValuesOfShortTermInvestments Short-term Investments - Amortized Cost and Estimated Fair Values of Short-Term Investments (Detail) false false R43.htm 144 - Disclosure - Short-term Investments - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformation Short-term Investments - Additional Information (Detail) false false R44.htm 145 - Disclosure - Inventories - Schedule of Inventories (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureInventoriesScheduleOfInventories Inventories - Schedule of Inventories (Detail) false false R45.htm 146 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShare Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) false false R46.htm 147 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareParenthetical Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Parenthetical) (Detail) false false R47.htm 148 - Disclosure - Net Loss Per Share - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation Net Loss Per Share - Additional Information (Detail) false false R48.htm 149 - Disclosure - Net Loss Per Share - Computation of Common Shares Upon Exercise of Warrants and Basic and Diluted Net Loss Per Share (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureNetLossPerShareComputationOfCommonSharesUponExerciseOfWarrantsAndBasicAndDilutedNetLossPerShare Net Loss Per Share - Computation of Common Shares Upon Exercise of Warrants and Basic and Diluted Net Loss Per Share (Detail) false false R49.htm 150 - Disclosure - Other Assets - Summary of Other Assets (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureOtherAssetsSummaryOfOtherAssets Other Assets - Summary of Other Assets (Detail) false false R50.htm 151 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilities Accrued Liabilities - Schedule of Accrued Liabilities (Detail) false false R51.htm 152 - Disclosure - Factoring and Security Agreement - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureFactoringAndSecurityAgreementAdditionalInformation Factoring and Security Agreement - Additional Information (Detail) false false R52.htm 153 - Disclosure - Debt - Schedule of Debt (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtScheduleOfDebt Debt - Schedule of Debt (Detail) false false R53.htm 154 - Disclosure - Debt - Schedule of Debt (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtScheduleOfDebtParenthetical Debt - Schedule of Debt (Parenthetical) (Detail) false false R54.htm 155 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) false false R55.htm 156 - Disclosure - Debt - Activity Related to Secured Promissory Note (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtActivityRelatedToSecuredPromissoryNote Debt - Activity Related to Secured Promissory Note (Detail) false false R56.htm 157 - Disclosure - Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtConsiderationReceivedFairValuesOfNotesCommonStockWarrantsIssuedAndCalculationOfTheGainOnExtinguishmentOfDebt Debt - Consideration Received, Fair Values of Notes, Common Stock Warrants Issued and Calculation of the Gain on Extinguishment of Debt (Detail) false false R57.htm 158 - Disclosure - Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureDebtActivityRelatedToSecuredPromissoryNoteParenthetical Debt - Activity Related to Secured Promissory Note (Parenthetical) (Detail) false false R58.htm 159 - Disclosure - Convertible Notes Payable - Summary of Convertible Notes Payable (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableSummaryOfConvertibleNotesPayable Convertible Notes Payable - Summary of Convertible Notes Payable (Detail) false false R59.htm 160 - Disclosure - Convertible Notes Payable - Summary of Convertible Notes Payable (Parenthetical) (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableSummaryOfConvertibleNotesPayableParenthetical Convertible Notes Payable - Summary of Convertible Notes Payable (Parenthetical) (Detail) false false R60.htm 161 - Disclosure - Convertible Notes Payable - Convertible Notes - Additional Information (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableConvertibleNotesAdditionalInformation Convertible Notes Payable - Convertible Notes - Additional Information (Detail) false false R61.htm 162 - Disclosure - Convertible Notes Payable - October 2012 Subordinated Convertible Note - Additional Information (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableOctober2012SubordinatedConvertibleNoteAdditionalInformation Convertible Notes Payable - October 2012 Subordinated Convertible Note - Additional Information (Detail) false false R62.htm 163 - Disclosure - Convertible Notes Payable - December 2012 Convertible Note - Additional Information (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableDecember2012ConvertibleNoteAdditionalInformation Convertible Notes Payable - December 2012 Convertible Note - Additional Information (Detail) false false R63.htm 164 - Disclosure - Convertible Notes Payable - First and Second May 2013 Convertible Notes - Additional Information (Detail) Notes http://www.marronebioinnovations.com/taxonomy/role/DisclosureConvertibleNotesPayableFirstAndSecondMay2013ConvertibleNotesAdditionalInformation Convertible Notes Payable - First and Second May 2013 Convertible Notes - Additional Information (Detail) false false R64.htm 165 - Disclosure - Stock Option Plans - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureStockOptionPlansAdditionalInformation Stock Option Plans - Additional Information (Detail) false false R65.htm 166 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) false false R66.htm 167 - Disclosure - Reverse Stock Split - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureReverseStockSplitAdditionalInformation Reverse Stock Split - Additional Information (Detail) false false R67.htm 168 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.marronebioinnovations.com/taxonomy/role/DisclosureInitialPublicOfferingAdditionalInformation Initial Public Offering - Additional Information (Detail) false false All Reports Book All Reports Element mbii_FairValueOfAdditionalCommonStockWarrantsIssued had a mix of decimals attribute values: -3 0. Element us-gaap_CommonStockSharesAuthorized had a mix of decimals attribute values: -3 0. Element us-gaap_DeferredFinanceCostsNet had a mix of decimals attribute values: -3 0. Element us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 had a mix of decimals attribute values: -3 0. Element us-gaap_PreferredStockSharesAuthorized had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromIssuanceInitialPublicOffering had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromNotesPayable had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensation had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised had a mix of decimals attribute values: -3 0. 'Shares' elements on report '107 - Statement - Condensed Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit)' had a mix of different decimal attribute values. 'Monetary' elements on report '107 - Statement - Condensed Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit)' had a mix of different decimal attribute values. 'Monetary' elements on report '108 - Statement - Condensed Consolidated Statements of Cash Flows' had a mix of different decimal attribute values. 'Monetary' elements on report '136 - Disclosure - Significant Accounting Policies - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '142 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '150 - Disclosure - Other Assets - Summary of Other Assets (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '159 - Disclosure - Convertible Notes Payable - Summary of Convertible Notes Payable (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Aug. 31, 2013' Process Flow-Through: 105 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 106 - Statement - Condensed Consolidated Statements of Comprehensive Loss Process Flow-Through: 108 - Statement - Condensed Consolidated Statements of Cash Flows Process Flow-Through: 109 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) mbii-20130930.xml mbii-20130930.xsd mbii-20130930_cal.xml mbii-20130930_def.xml mbii-20130930_lab.xml mbii-20130930_pre.xml true true